Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Fibroblast growth factor, estrogen, and prolactin receptor features in different grades of prostatic adenocarcinoma in elderly men
Author: Hetzl, AC
Montico, F
Lorencini, RM
Kido, L
Candido, E
Billis, A
Ferreira, U
Ha Cagnon, V
Abstract: The objective was to characterize and associate the receptor reactivities of fibroblastic growth factor (FGF)-2, FGF-7, FGF-8, epidermal growth factor (EGF), -actin and vimentin in relation to the androgen receptor (AR), and estrogen receptors (ER and ER), and prolactin receptor in the prostate of elderly men showing low- and high-grade adenocarcinoma. Thirty prostatic samples were taken from 60- to 90-year-old patients without prostatic lesions and with low-grade cancer and high-grade cancer, from the University Hospital, School of Medicine, the State University of Campinas. The results showed that increased FGF-2, FGF-7, and FGF-8 receptor reactivities and decreased AR reactivity were verified in both high- and low-grade cancer. However, the FGF-8 receptor showed greater involvement at the beginning of the malignancy alterations. Increased EGF receptor (EGFR) reactivity and diminished -actin immunohistochemistry were identified in both cancer groups. Also, increased ER, PR, and vimentin receptors were verified in both cancer groups. To conclude, the ER involvement in the reactive stroma activation led to a microenvironment, which was favorable to cancer progression, due to maximizing stromal imbalance. The prolactin could be related to cancer progression due to its interaction with ER action, indicating that this hormone could be a relevant target to prevent the estrogenic effects in the prostatic lesions. Both FGF receptor (FGFR)-2 and FGFR-8 play a fundamental role in the early stages of prostate cancer, suggesting that these molecules could be a promising therapeutic target. The differential localization of the fibroblastic factors between the prostatic epithelium and stroma of elderly men, who presented prostate cancer, could indicate a favorable distinction for tumoral progression. Microsc. Res. Tech. 76:321330, 2013. (c) 2013 Wiley Periodicals, Inc.
Subject: prostate
fibroblast growth factors
hormone steroids
Country: EUA
Editor: Wiley-blackwell
Citation: Microscopy Research And Technique. Wiley-blackwell, v. 76, n. 3, n. 321, n. 330, 2013.
Rights: fechado
Identifier DOI: 10.1002/jemt.22170
Date Issue: 2013
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.